1. Zalewska-Szewczyk B, Matusiak I, Wyka K, et al. Changes in the lipid profile in children with acute lymphoblastic leukaemia – the influence of the disease and its treatment. Med Wieku Rozwoj 2008; 12: 1035–1040.
2.
Madan D, Aggarwal P, Jain A, et al. Lipid profile during chemotherapy in children with acute lymphoblastic leukemia. Indian J Cancer 2021; 58(3): 461–462, doi: 10.4103/ijc.IJC_280_20.
3.
Naik PP, Ghadge MS, Raste AS. Lipid profile in leukemia and Hodgkin’s disease. Indian J Clin Biochem 2006; 21(2): 100–102, doi: 10.1007/BF02912921.
4.
Mogensen PR, Grell K, Schmiegelow K, et al. Dyslipidemia at diagnosis of childhood acute lymphoblastic leukemia. PLOS ONE 2020; 15(4): e0231209, doi: 10.1371/journal.pone.0231209.
5.
Bélanger V, Morel S, Napartuk M, et al. Abnormal HDL lipid and protein composition following pediatric cancer treatment: an associative study. Lipids Health Dis 2023; 22(1), doi: 10.1186/s12944-023-01822-2.
6.
Maan M, Peters JM, Dutta M, et al. Lipid metabolism and lipophagy in cancer. Biochem Biophys Res Commun 2018; 504(3): 582–589, doi: 10.1016/j.bbrc.2018.02.097.
7.
Schmiegelow K, Müller K, Mogensen SS, et al. Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy. F1000Res 2017; 6: 444, doi: 10.12688/f1000research.10768.1.
8.
Frazier AL, Orjuela-Grimm MA, Dietz W. Obesity in pediatric oncology: Assessment, treatment strategies, and knowledge gaps. J Natl Cancer Inst Monogr 2019; 2019(54): 139–143, doi: 10.1093/jncimonographs/lgz024.
9.
Gibson TM, Ehrhardt MJ, Ness KK. Obesity and Metabolic Syndrome Among Adult Survivors of Childhood Leukemia. Curr Treat Options Oncol 2016; 17(4): 14, doi: 10.1007/s11864-016-0393-5.
10.
Mazur A, Zachurzok A, Baran J, et al. Childhood Obesity: Position Statement of Polish Society of Pediatrics, Polish Society for Pediatric Obesity, Polish Society of Pediatric Endocrinology and Diabetes, the College of Family Physicians in Poland and Polish Association for Study on Obesity. Nutrients 2022; 14(18): 1–41, doi: 10.3390/nu14183806.
11.
Weihrauch-Blüher S, Schwarz P, Klusmann JH. Childhood obesity: increased risk for cardiometabolic disease and cancer in adulthood. Metabolism 2019; 92: 147–152, doi: 10.1016/j.metabol.2018.12.001.
12.
Krawczuk-Rybak M, Panasiuk A, Stachowicz-Stencel, T, et al. Health status of Polish children and adolescents after cancer treatment. Eur J Pediatr 2018; 177(3): 437–447, doi: 10.1007/s00431-017-3066-x.
13.
Morel S, Leahy J, Fournier M, et al. Lipid and lipoprotein abnormalities in acute lymphoblastic leukemia survivors. J Lipid Res 2017; 58(5): 982–993, doi: 10.1194/jlr.M072207.
14.
Rajendran R, Abu E, Fadl A, et al. Late effects of childhood cancer treatment: Severe hypertriglyceridaemia, central obesity, non alcoholic fatty liver disease and diabetes as complications of childhood total body irradiation. Diabet Med 2013; 30(8): 12234, doi: 10.1111/dme.12234.
15.
Konończuk K, Latoch E, Żelazowska-Rutkowska B, et al. Increased levels of adipocyte and epidermal fatty acid-binding proteins in acute lymphoblastic leukemia survivors. J Clin Med 2021; 10(8): 1567, doi: 10.3390/jcm10081567.
16.
Krzystek-Korpacka M, Patryn E, Bednarz-Misa I, et al. Circulating adipocyte fatty acid-binding protein, juvenile obesity, and metabolic syndrome. J Pediatr Endocrinol Metab 2011; 24(11–12): 921–928, doi: 10.1515/jpem.2011.323.
17.
Blüher S, Käpplinger J, Herget S, et al. Cardiometabolic risk markers, adipocyte fatty acid binding protein (aFABP) and the impact of high-intensity interval training (HIIT) in obese adolescents. Metabolism 2017; 68: 77–87, doi: 10.1016/j.metabol.2016.11.015.
18.
Lee CH, Lui DTW, Lam KSL. Adipocyte Fatty Acid-Binding Protein, Cardiovascular Diseases and Mortality. Front Immunol 2021; 12: 589206, doi: 10.3389/fimmu.2021.589206.
19.
Steliarova-Foucher E, Colombet M, Ries LAG, et al. International incidence of childhood cancer, 2001–10: a population-based registry study. Lancet Oncol 2017; 18(6): 719–731.
20.
Palczewska I, Niedźwiecka Z. Zakład Rozwoju Dzieci i Młodzieży Instytutu Matki i Dziecka. Siatki Centylowe do Oceny Rozwoju Somatycznego Dzieci i Młodzieży; 1999. Available from URL: http://i.wp.pl/a/i/szkola2/pdf/siatki_centylowe.pdf (in Polish).
21.
Frisancho AR. Anthropometric Standards for the Assessment of Growth and Nutritional Status. Ann Arbor (MI): University of Michigan Press; 1990, doi: 10.1002/ajpa.1330840116.
22.
Pizzo PA, Poplack DG. Principles and Practice of Pediatric Oncology. Philadelphia: Lippincott Williams & Wilkins; 2011.
23.
Styczyński J, Balwierz W, Dembowska-Bagińska B, et al. Paediatric oncology and haematology in Poland: Position paper. Pediatr Pol 2018; 93(6): 451–461, doi: 10.5114/polp.2018.82653.
24.
Pires A, Sena C, Seiça R. Dyslipidemia and cardiovascular changes in children. Curr Opin Cardiol 2016; 31(1): 95–100, doi:10.1097/HCO.0000000000000249.
25.
Cepelova M, Kruseova J, Luks A, et al. Accelerated atherosclerosis, hyperlipoproteinemia and insulin resistance in long-term survivors of Hodgkin lymphoma during childhood and adolescence. Neoplasma 2019; 66(6): 978–987, doi: 10.4149/neo_2019_190115N45.
26.
Kartal İ, Alaçam A, Dağdemir A, et al. Frequency of obesity and metabolic syndrome in childhood leukemia and lymphoma survivors. Diabetol Metab Syndr 2022; 14(1): 16, doi: 10.1186/s13098-022-00790-4.
27.
Laumann RD, Pedersen LL, Andrés-Jensen L, et al. Hyperlipidemia in children and adolescents with acute lymphoblastic leukemia: A systematic review and meta-analysis. Pediatr Blood Cancer 2023; 70(12): e30683, doi: 10.1002/pbc.30683.
28.
Ioannidou M, Avgeros C, Tsotridou E, et al. Lipid Profile of Children with Acute Lymphoblastic Leukemia during L-Asparaginase Treatment. Hippokratia 2023; 27(2): 41–47.
29.
Moschovi M, Trimis G, Apostolakou F, et al. Serum Lipid Alterations in Acute Lymphoblastic Leukemia of Child-hood. J Pediatr Hematol Oncol 2004; 26(5): 289–293, doi: 10.1097/00043426-200405000-00006.
30.
Brinksma A, Huizinga G, Sulkers E, et al. Malnutrition in childhood cancer patients: A review on its prevalence and possible causes. Crit Rev Oncol Hematol 2012; 83(2): 249–275, doi: 10.1016/j.critrevonc.2011.12.003.
31.
Iniesta RR, Paciarotti I, Brougham MFH, et al. Effects of pediatric cancer and its treatment on nutritional status: A systematic review. Nutr Rev 2015; 73(5): 276–295, doi: 10.1093/nutrit/nuu062.
32.
Barr RD, Stevens MCG. The influence of nutrition on clinical outcomes in children with cancer. Pediatr Blood Cancer 2020; 67(S3): 1–11, doi: 10.1002/pbc.28117.
33.
Warris LT, Akker EL, van den, Bierings MB, et al. Acute activation of metabolic syndrome components in pediatric acute lymphoblastic leukemia patients treated with dexamethasone. PLOS ONE 2016; 11(6): e0158225, doi: 10.1371/journal.pone.0158225.
34.
Banaś IM, Lewek PK, Kardas P. In which group of children and adolescents should a family doctor look for metabolic syndrome? Fam Med Prim Care Rev 2016; 18(3): 217–220, doi: 10.5114/fmpcr/63333.
35.
Dencker M, Danielson A, Karlsson MK, et al. Total body fat, abdominal fat, body fat distribution and surrogate markers for health related to adipocyte fatty acid-binding protein (FABP4) in children. J Pediatr Endocrinol Metab 2017; 30(4): 375–382, doi: 10.1515/jpem-2016-0278.36.
36.
Kralisch S, Fasshauer M. Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease? Diabetologia 2013; 56(1): 10–21, doi: 10.1007/s00125-012-2737-4.
37.
Gustafsson J. Metabolic syndrome in children. Acta Paediatr 2019; 108(3): 394–395, doi: 10.1111/apa.14677.
